Higher CAC burden strongly associates with incident SCD beyond traditional risk factors, particularly among primary prevention patients with low-intermediate risk. SCD risk stratification can be useful in the early stages of CHD through the measurement of CAC, identifying patients most likely to benefit from further downstream testing.
EditorsEditor-in-ChiefY.S. Chandrashekhar, MD, DM, FACCCME EditorRagavendra R. Baliga, MDAuthorAhmad M. Slim, MD, FACCImportant DatesDate of Release: July 4, 2022Term of Approval/Date of CME/MOC/ECME Expiration: July 3, 2023